Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
38,109,969
-
Shares change
-
+2,427,996
-
Total reported value, excl. options
-
$635,678,067
-
Value change
-
+$18,883,443
-
Put/Call ratio
-
446%
-
Number of buys
-
62
-
Number of sells
-
-64
-
Price
-
$16.68
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2017
177 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,109,969 shares
of 80,437,135 outstanding shares and own 47.38% of the company stock.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (4,143,270 shares), RTW INVESTMENTS, LP (4,130,115 shares), BlackRock Inc. (3,093,399 shares), Vanguard Group Inc (2,775,655 shares), STATE STREET CORP (2,724,315 shares), D. E. Shaw & Co., Inc. (2,608,432 shares), Boxer Capital, LLC (1,750,000 shares), FMR LLC (1,158,154 shares), GREAT POINT PARTNERS LLC (1,085,800 shares), and Spark Investment Management LLC (1,037,200 shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.